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Prognostic Significance of Blood Pressure and
Heart Rate Variabilities
The Ohasama Study
Masahiro Kikuya, Atsushi Hozawa, Takayoshi Ohokubo, Ichiro Tsuji, Mari Michimata,
Mitsunobu Matsubara, Masahiro Ota, Kenichi Nagai, Tsutomu Araki, Hiroshi Satoh,
Sadayoshi Ito, Shigeru Hisamichi, Yutaka Imai
Abstract—To investigate the association between cardiovascular mortality and short-term variabilities in blood pressure
and heart rate, we performed a long-term prospective study of ambulatory blood pressure monitoring in Ohasama, Japan,
starting in 1987. We obtained ambulatory blood pressure and heart rate in 1542 subjects $40 years of age. Blood
pressure and heart rate variabilities were estimated as a standard deviation measured every 30 minutes by ambulatory
monitoring. There were 67 cardiovascular deaths during the follow-up period (mean58.5 years). The Cox proportional
hazards model, adjusted for possible confounding factors, demonstrated a significant increase in cardiovascular
mortality, with an increase in daytime systolic ambulatory blood pressure variability. A similar trend was observed in
daytime diastolic and nighttime ambulatory blood pressures. Cardiovascular mortality rate increased linearly, with a
decrease in daytime heart rate variability. Subjects in whom the daytime systolic ambulatory blood pressure variability
was larger than third quintile and the daytime heart rate variability was lower than the mean2SD were at extremely high
risk of cardiovascular mortality. The blood pressure and heart rate variabilities obtained every 30 minutes by ambulatory
blood pressure monitoring were independent predictors for cardiovascular mortality in the general population.
(Hypertension. 2000;36:901-906.)
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Blood pressure (BP) variability estimated as a standarddeviation of beat-to-beat BP obtained by intra-arterial
BP monitoring has been suggested to be a risk factor for
hypertension-related target organ damage.1,2 BP variability
estimated as a standard deviation of noninvasive ambulatory
BP monitoring obtained by every 15 to 20 minutes measure-
ment is also associated with cardiovascular morbidity and
mortality.3,4 However, the prognostic significance of BP
variability for cardiovascular mortality has not been investi-
gated in the general population. We started a long-term
prospective cohort study with ambulatory BP monitoring in
the general population of a rural Japanese community and
monitored the survival of this population from 1987.5–9 In this
study, we investigated the association between the baseline
BP and heart rate (HR) variabilities and subsequent cardio-
vascular mortality in the general population.
Most previous studies assessing HR variability examined
beat-to-beat HR variability obtained by Holter monitoring. A
clinical significance of BP and HR variability obtained by
indirect and intermittent measurement may be different from
that of previous studies in which beat-to-beat intra-arterial BP
monitoring and Holter monitoring of HR were applied.10
However, monitoring of ambulatory BP and HR every 30
minutes is widely used in clinical practice. Therefore, we
examined the predictive power of BP and HR variability
obtained every 30 minutes for cardiovascular mortality.
Methods
Study Population
The subjects took part in a longitudinal, observational study of
ambulatory BP monitoring in the general population of Ohasama, a
rural community of Japan, starting in 1987. The details of the
Ohasama study have been reported elsewhere.5–9 Of the 2716
individuals $40 years of age in 3 of the 4 districts of Ohasama, we
excluded individuals who worked outside the town (n5575), were
hospitalized (n5121), or were demented or bedridden (n531). We
obtained ambulatory BP data on 1542 subjects (mean age 61.7 years;
ratio of men to women, 40: 60). We had confirmed previously that
the subjects were representative of the general Japanese popula-
tion.7,8 Informed consent was obtained from all subjects, and the
study was approved by the Institutional Review Board of Tohoku
University School of Medicine.
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Ambulatory BP Monitoring
The ambulatory BP and HR were monitored every 30 minutes with
a fully automatic device (ABPM630, Nippon Colin) that met the
criteria of the Association for the Advancement of Medical Instru-
mentation.11,12 We used the cuff-oscillometric method for analysis.
Participants were told to carry on with their normal daily activities
during measurement. According to the diary, “daytime” and “night-
time” were determined as the waking and sleeping periods of the
patient, respectively. The mean duration of monitoring was 22.662.4
hours, and the mean number of measurements was 45.264.9
(n51542). Artifacts of BP measurements during monitoring were
defined according to previously described criteria13 and were omitted
from the analysis. We only analyzed the ambulatory BP data that
were obtained for .8 hours and 4 hours during the daytime and
nighttime, respectively.
Data Analysis
We investigated the association between the baseline BP and HR
variabilities and subsequent cardiovascular mortality in this general
population.
Residence in Ohasama as of March 31, 2000, was confirmed by
examining the residents’ registration cards. The mean duration of
follow-up was 8.5 years (SD 2.4, maximum 11.8 years). We obtained
death certificates from the Ohasama Health Department. We also
reviewed hospital record forms and confirmed the cause of death.
According to the recommendations of the 10th revision of the World
Health Organization’s International Classification of Diseases, car-
diovascular death was defined as mortality related to disease of the
circulatory system (ICD-10 code “I”). The characteristics of the
causes of death in the Ohasama study have been described previous-
ly.9 Of the 1542 residents who were eligible for the study, 17 (1.5%)
moved away or were lost to follow-up. There were 195 deaths
(12.6%) during the follow-up period, of which 67 were caused by a
cardiovascular event.
In this study, we focused on BP variability every 30 minutes, that
is, short-term variability rather than circadian BP variation. We
previously reported that the magnitude of the nocturnal decline in
BP, which is an index of circadian BP variation, was the strongest
predictor of the SD of 24-hour BP, suggesting that the SD of 24-hour
BP is not an appropriate index of short-term BP variability.14
Therefore, short-term BP variability (every 30 minutes) was calcu-
lated as the SD of daytime and nighttime ambulatory BP, respec-
tively. Similarly, we calculated the SD of daytime and nighttime HR
obtained every 30 minutes by an ambulatory BP monitoring device
and defined it as HR variability.
The prognostic significance of BP and HR variabilities was
determined by means of the Cox proportional hazards regression
model15 with the SAS PHREG procedure.16 The dependent variable
was the number of days from the measurement of ambulatory BP to
cardiovascular death or “censoring” (noncardiovascular death or
withdrawal from this study for survivors on March 31, 2000). The
independent variables were baseline BP and HR variabilities, BP
level, gender, age, smoking status, obesity, use of antihypertensive
medication, and history of hyperlipidemia, diabetes mellitus, and
cardiovascular disease.
Initially, quintile analysis was applied to the baseline BP variabil-
ity, in which subjects were subdivided equally into 5 groups
according to the distribution of the variability. We treated the
quintile associated with the lowest mortality risk as a reference
category. In analyzing the association between HR variability and
prognosis, participants were subdivided into 3 groups: HR variabil-
ity , mean2SD, mean2SD , HR variability , mean1SD, HR
variability . mean1SD, according to the previous report indicating
the prognostic significance of HR variability.17 In this analysis, we
treated the tertile of HR variability associated with the lowest
mortality risk as a reference category. One of the objectives of this
study was to investigate whether the relation between BP variability
and cardiovascular mortality risk is linear or not. To determine the
linearity between BP variability and cardiovascular mortality risk,
we applied quintile analysis, whereas the relation between HR
variability and cardiovascular mortality risk was assessed by tertiles
analysis, because the latter relation has already been reported in the
previous work.17 Differences of BP variabilities among the quintiles
and of HR variabilities among 3 groups were tested for the presence
of linear trends by Cox proportional hazards model. We then
performed Cox proportional hazards analysis to determine the
association between cardiovascular mortality and BP variability, in
which HR variability was included in the regression model as a
continuous variable. Similarly, in the analysis of the association
between cardiovascular mortality and HR variability, BP variability
was adjusted. After this, we performed Cox proportional hazards
analysis again to determine the association between cardiovascular
mortality and the combination of BP and HR variabilities
Information on smoking status, history of cardiovascular disease,
and use of antihypertensive medication was obtained from question-
naires sent to each subject at the time of ambulatory BP monitoring
and was confirmed from the medical records at Ohasama Hospital. A
history of cardiovascular disease included a history of stroke
incidence, transient ischemic attacks, myocardial infarction, angina
pectoris, atrial fibrillation, and cardiac or renal failure.
The estimated relative hazard (RH) and 95% confidence interval
(CI) of the variables were derived from the coefficient and its
standard error as determined by the Cox proportional hazards model.
Data are shown as mean1SD. A value of P,0.05 was accepted as
indicating statistical significance.
Results
The baseline characteristics of participants among the quin-
tiles of BP variability estimated as the SD of daytime systolic
ambulatory BP and among the 3 groups of HR variability
(HR variability , mean2SD, mean2SD , HR variability ,
mean1SD, HR variability . mean1SD) are shown in Tables
1 and 2, respectively. Age, BP level, the prevalence of
antihypertensive medication, obesity, and hyperlipidemia in-
creased significantly, as did daytime systolic BP variability
(Table 1). The prevalence of previous cardiovascular disease
tended to increase, whereas the prevalence of male gender
and current or ex-smokers significantly decreased with an
increase in systolic BP variability, respectively. The baseline
characteristics of participants among the quintiles of daytime
diastolic BP and nighttime systolic and diastolic BP variabil-
ity showed similar results.
The levels of 24-hour and daytime HR significantly increased,
as did daytime HR variability (Table 2). The prevalence of
hyperlipidemia tended to increase with a decrease in daytime
HR variability. The other variables showed no consistent
association.
Figure 1 shows the RH and 95% CI for cardiovascular
mortality among the quintiles of daytime and nighttime
ambulatory BP variability and among the 3 groups of HR
variability (HR variability , mean2SD, mean2SD , HR
variability , mean1SD, HR variability . mean1SD).
There was a significant linear relation between daytime
systolic ambulatory BP variability and RH for cardiovas-
cular mortality (P for linear trend50.03). Cardiovascular
mortality rate increased linearly, with a decrease in day-
time HR variability (P for linear trend50.008). Of 392
treated subjects, 105 (26.8%) were treated with b-blockers.
When we adjusted the use of b-blockers, the results of RH
of daytime HR variability (P for linear trend50.009) were
similar to those in which the use of antihypertensive
medication was adjusted. The RH of daytime HR variabil-
ity in the mid (7.2 to 14.0 bpm) and the lowest tertiles
(,7.2 bpm) was 2.14 (95% CI 0.76 to 6.15, P50.15) and
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3.64 (95% CI 1.22 to 10.8, P50.02), respectively. Such an
association was not observed for nighttime HR variability.
The highest quintiles of daytime and nighttime systolic BP
variability were associated with a significant increase in
the risk of cardiovascular mortality.
To exclude the effect of a reciprocal relation between HR and
BP variabilities on cardiovascular mortality, we further adjusted
these variables as confounding factors against each other in the
Cox regression model (Table 3). This adjustment did not change
the results indicated in Figure 1, suggesting that BP and HR
variabilities are associated with cardiovascular mortality inde-
pendent of each other. Analysis with nighttime BP and HR
variability gave a similar result to that shown in Figure 1.
Figure 2 indicates the prognostic significance of the com-
binations of daytime ambulatory BP and HR variabilities.
These were divided at the third quintiles of daytime ambula-
tory BP variability (15.8 mm Hg) and the mean2SD of HR
variability (7.2 bpm). Subjects in whom the daytime systolic
ambulatory BP variability was larger than the third quintile
and the daytime HR variability was simultaneously less than
mean2SD showed an extremely high risk of cardiovascular
mortality (RH53.56, P,0.01).
Discussion
The prognostic value of BP variability was first confirmed in
this long-term prospective study of the general population,
TABLE 1. Clinical Characteristics Among Quintiles of Daytime Ambulatory Blood
Pressure Variability
Variables
Daytime Systolic BP Variability, mm Hg
P,11.5 11.5–13 13–15.8 15.8–18.8 18.8,
No. of subjects 312 314 301 307 308
Age, y 55 60 61 64 68 0.0001*
Ambulatory BP, mm Hg
24-h systolic 116 122 124 126 129 0.0001*
24-h diastolic 69 72 73 73 74 0.0001*
Daytime systolic 121 126 130 132 136 0.0001*
Daytime diastolic 73 75 77 77 78 0.0001*
Nighttime systolic 105 111 113 115 118 0.0001*
Nighttime diastolic 61 64 65 65 66 0.0001*
Men, % 45 41 35 35 28 0.001†
Antihypertensive medication, % 10 25 35 34 50 0.001†
Smoking, % 29 23 20 20 16 0.005†
Obesity, % 24 25 32 31 37 0.002†
Hyperlipidemia, % 11 12 15 19 24 0.001†
Diabetes, % 14 17 18 19 18 NS
Previous cardiovascular disease, % 2 7 4 3 7 0.003†
*ANOVA, †x2 test.
TABLE 2. Clinical Characteristics Among 3 Groups of HR Variability (HR
Variability<Mean2SD, Mean2SD<HR Variability<Mean1SD, HR
Variability>Mean1SD)
Variables
Daytime HR Variability, bpm
P,7.2 7.2–14.0 14.0,
No. of subjects 231 1087 224 0.0001*
Age, y 64 61 62 0.0001*
24 h HR, bpm 65 69 70 0.0001*
Daytime HR, bpm 68 74 77 0.0001*
Nighttime HR, bpm 59 60 57 0.0001*
Men, % 41 35 41 NS
Antihypertensive medication, % 39 28 34 0.003†
Smoking, % 23 21 22 NS
Obesity, % 34 29 31 NS
Hyperlipidemia, % 19 16 12 NS
Diabetes, % 17 17 17 NS
Previous cardiovascular disease, % 5 4 6 NS
*ANOVA, †x2 test.
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that is, the greater the SD of ambulatory systolic BP, the
greater the risk of cardiovascular mortality. BP variability
monitored intra-arterially has been suggested to be a risk
factor for hypertension-related target organ damage.1,2 Every
15 to 20 minutes, BP variability estimated as a standard
deviation (SD) of noninvasive ambulatory BP monitoring is
also associated with cardiovascular morbidity and mortali-
ty.3,4 For example, in the Cornell study, 729 individuals with
mild hypertension were followed up for an average of 5 years,
and the Cox model was adjusted for possible confounding
factors to demonstrate that the SD of ambulatory diastolic BP
was an independent predictor of cardiovascular morbidity.
As also described in previous reports,4,14,18–20 this study
demonstrated that BP variability increased as did BP and age.
High BP variability was also associated with a prevalence of
obesity and hyperlipidemia. To investigate the prognostic
significance of BP variability independent from these risk
factors, we adjusted the possible confounding factors for Cox
analysis and confirmed a significant linear relation between
daytime systolic BP variability and RH for cardiovascular
mortality. Such a relation was not confirmed by Verdecchia et
al,4 who followed up 1372 hypertensive subjects for 2.9 years
with noninvasive ambulatory BP monitoring every 15 min-
utes. The differences in the duration of the follow-up period
and in the study population (general population versus hy-
pertensive subjects) may have influenced the variation in
results between the two studies. The difference in the age of
the participants (61.7 years in our study versus 52 years in the
study by Verdecchia et al) may also have been a significant
factor.
The increase in BP variability in hypertensive and elderly
subjects may be partly explained by the diminished barore-
flex function associated with increased stiffness and de-
creased compliance of the large elastic arteries caused by
aging and hypertension.14,21,22 A disturbed baroreflex func-
tion is related to an exaggerated pressor response to mental
Figure 1. RH and 95% CI for cardiovascular mortality among quintiles of ambulatory BP variability and among 3 groups of HR variabil-
ity (HR variability , mean2SD, mean2SD , HR variability , mean1SD, HR variability . mean1SD). RH and 95% CI were determined
by Cox proportional hazards model, adjusted for gender, age, smoking status, obesity, use of antihypertensive medication, history of
hyperlipidemia, diabetes mellitus, cardiovascular disease, and 24-hour systolic and diastolic BP levels. For HR variability, risk was fur-
ther adjusted for 24-hour HR level. Number inside bar shows 95% CI. P for linear trend is indicated. *P,0.05 vs RH51.0.
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and physical stimuli and mediates orthostatic hypotension,
postprandial hypotension, and other conditions, resulting in
increased BP variability. HR variability positively correlates
baroreflex sensitivity.20 An inverse relation between BP and
HR variabilities also reflects baroreflex function22; HR vari-
ability is mediated reflexly by BP variability and buffers BP
variability. High BP variability is assumed to be mediated at
least in part by disturbed cardiac baroreflex function. How-
ever, after adjusting HR variability in this study, BP variabil-
ity was still an independent risk factor for cardiovascular
mortality. Therefore, it is unlikely that impaired baroreflex
function is the sole mechanism explaining the relation be-
tween high BP variability and poor prognosis. However, it is
still uncertain whether a clinical significance of BP and HR
variabilities every 30 minutes are equivalent to that of
beat-to-beat BP and HR variabilities and thus whether BP and
HR variabilities every 30 minutes reflect baroreflex function.
The mechanisms controlling short-term (beat-to-beat) and
long-term (every 30 minutes) BP and HR variabilities may be
different and thus relations between BP and HR variabilities
obtained by measurement every 30 minutes and outcome and
those obtained by beat-to-beat measurement and outcome
may be mediated by different mechanisms. Another possible
mechanism is that high BP variability injures the blood vessel
and consequently causes cardiovascular complications. The
effect of phasic BP load on cardiovascular structures is
considered to be as important as that of tonic BP load.23
Poor prognosis in subjects with reduced HR variability has
been reported in several types of cardiovascular disease such
as congestive heart failure, post–myocardial infarction, and
diabetes mellitus.24–26 However, the clinical significance of
HR variability has not been well studied in the general
population. In the Framingham Heart Study, Tsuji et al17
reported that less than the mean2SD of the SD of the total
R-R intervals in individuals obtained by Holter ECG was
associated with a hazard ratio of 1.47 for cardiac events. In
our study, the prognostic significance of the HR variability
obtained by ambulatory BP monitoring was similar to that
reported by Tsuji et al, in which HR variability was obtained
by Holter monitoring of ECG. HR variability obtained by
ambulatory BP monitoring may be different, both qualita-
tively and quantitatively, from that obtained by Holter mon-
itoring. However, our study demonstrated that the HR vari-
ability obtained even every 30 minutes has prognostic
significance for cardiovascular mortality.
Only ambulatory BP monitoring can provide information
on BP and BP variability as well as HR and HR variability.
After adjusting BP variability in this study, HR variability
was still an independent risk factor for cardiovascular mor-
tality and vice versa, suggesting that HR and BP variabilities
are associated with cardiovascular mortality independent of
BP variability and HR variability, respectively. The combi-
nation of 2 independent variables such as BP and HR
variabilities provided a powerful predictor of future cardio-
vascular mortality (Figure 2). Therefore, it is possible that
indirect and intermittent ambulatory BP monitoring is more
effective than the Holter ECG in predicting future cardiovas-
cular morbidity or mortality.
Although we adjusted the use of antihypertensive medica-
tion in this analysis, it is possible that antihypertensive drugs
may have affected the BP and HR variabilities. This in turn
may have altered the prognostic power of BP and HR
variability. To resolve this problem, a further long-term
prospective study in a younger general population who are
not taking antihypertensive drugs is needed.
In conclusion, the BP and HR variabilities obtained every
30 minutes by ambulatory BP monitoring were independent
TABLE 3. RH and 95% CI of Daytime Ambulatory BP
Variability and HR Variability for Cardiovascular Mortality,
Adjusted for Gender, Age, Use of Antihypertensive Medication,
Smoking Status, Obesity, History of Hyperlipidemia, Diabetes,
Cardiovascular Disease, 24-Hour Systolic BP, Diastolic BP,
and HR Levels
Variables RH 95% CI Trend P
Daytime systolic BP
variability, mm Hg
,11.5 1.76 0.53–5.85
11.5–13.9 1.00
13.9–15.8 1.22 0.44–3.38 0.02
15.8–18.8 2.08 0.85–5.07
18.8, 2.69* 1.18–6.13
Daytime diastolic BP
variability, mm Hg
,7.3 1.16 0.35–3.82
7.3–8.6 1.00
8.6–10.1 1.53 0.58–4.04 0.04
10.1–12.1 1.74 0.70–4.32
12.1, 2.39 0.99–5.72
Daytime HR variability, bpm
,7.2 4.45† 1.47–13.4
7.2–14.0 2.52 0.89–7.13 0.003
14.0, 1
RH of daytime BP variability and daytime HR variability were further adjusted
for daytime HR variability and daytime BP variability, respectively.
*P,0.05, †P,0.01.
Figure 2. RH and 95% CI for cardiovascular mortality among
combinations of daytime ambulatory BP variability and HR vari-
ability. BP and HR variabilities were divided at third quintile of
daytime ambulatory BP variability and mean2SD of HR variabil-
ity, respectively. RH and 95% CI were determined by Cox pro-
portional hazards model, adjusted for gender, age, use of anti-
hypertensive medication, smoking status, obesity, history of
hyperlipidemia, diabetes, cardiovascular disease, and 24-hour
systolic and diastolic BP and HR levels. *P,0.01 vs RH51.0.
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predictors for cardiovascular mortality in the general
population.
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